Brain Tumor Treatments: Chemotherapy
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Chemotherapy
Please scroll down past the trials to see pages on this site about this topic!
  Showing Treatment 1 to 25 of 1137 Next 25 Location Last Updated
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Pittsburgh, PA USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Dallas, TX USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Los Angeles, CA USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) New York, NY USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Edison, NJ USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Orlando, FL USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Chicago, IL USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Scarborough, ME USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Danville, PA USA 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Graz, Austria 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Kiel, Germany 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Hamburg, Germany 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Tel Aviv, Israel 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Milan, Italy 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Milan, Italy 07/18/2010
Details Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) San Diego, CA USA 07/18/2010
Details Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status (CORE) Rochester, NY USA 07/18/2010
Details Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma (HBO) Great Neck & Commack, NY USA 06/02/2010
Details Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Great Neck & Commack, NY USA 06/02/2010
Details Cilengitide for Subjects With Newly Diagnosed Glioblastoma Multiforme and Methylated MGMT Gene Promoter - A Multicenter, Open-Label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy) Versus Standard Treatment Alone Rochester, NY USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Pittsburgh, PA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Berkeley, CA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma New Orleans, LA USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Akron, OH USA 04/13/2010
Details Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Cleveland, OH USA 04/13/2010

(Relevance) Page Title - click title to go to the page!

  (0.9017)   Medulloblastoma
  (0.8792)   Trials by NCT number
  (0.8658)   Chemotherapy For Brain Tumors
  (0.8510)   Brain Tumor Treatments: Chemotherapy
  (0.8510)   Trials without an NCT number
  (0.7967)   Brain Tumor Treatments: China PR
  (0.7967)   Brain Tumor Treatments: Netherlands
  (0.7967)   Brain Tumor Treatments: Nebraska
  (0.7967)   Brain Tumor Treatments: North Dakota
  (0.7967)   Brain Tumor Treatments: Montana
  (0.7967)   Brain Tumor Treatments: Mississippi
  (0.7967)   Search for a Specific Trial or Treatment
  (0.7967)   Brain Tumor Treatments: Maine
  (0.7967)   Emerging Med Trials Matcher
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Links to More Brain Tumor Information
  (0.7967)   Brain Tumor Treatments: Kentucky
  (0.7967)   Brain Tumor Treatments: Kansas
  (0.7967)   Brain Tumor Treatments: Indiana
  (0.7967)   Brain Tumor Treatments: Idaho
  (0.7967)   Brain Tumor Treatments: Iowa
  (0.7967)   Brain Tumor Treatments: Hawaii
  (0.7742)   Brain Tumor Guide
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain tumor Chat room registration
  (0.7742)   Problem Report Received
  (0.7742)   Brain Tumor Chat Room Problem
  (0.7742)   Brain Tumor Treatments: North Carolina
  (0.7742)   Musella Foundation
  (0.7742)   Mohammad Abdollahian
  (0.7742)   Brain Tumor Treatments: Missouri
  (0.7742)   Brain Tumor Treatments: Minnesota
  (0.7742)   Brain Tumor Treatments: Michigan
  (0.7742)   TEST
  (0.7742)   virtualtrials.com/menu2006b.cfm
  (0.7742)   virtualtrials.com/menu2006.cfm
  (0.7742)   Meningioma List
  (0.7742)   Meningioma List
  (0.7742)   Memorials
  (0.7742)   Memorials
  (0.7742)   Memorial
  (0.7742)   Brain Tumor Treatments: Maryland
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Map
  (0.7742)   Brain Tumor Treatments: Malaysia
  (0.7742)   Newsletter And Daily News Update!
  (0.7742)   Mailbox
  (0.7742)   Brain Tumor Treatments: Massachusetts
  (0.7742)   Brain Tumor Treatments: Less Toxics
  (0.7742)   Online Support Groups
  (0.7742)   Links (webTV version)
  (0.7742)   Add a Links to Brain Tumor Information
  (0.7742)   Add a Links to Brain Tumor Information
  (0.7742)   Letter Writing Campaign
  (0.7742)   Brain Tumor Treatments: Less Toxics
  (0.7742)   Brain Tumor Treatments: Less-Toxic
  (0.7742)   Brain Tumor Treatments: Louisiana
  (0.7742)   Karnofsky Score
  (0.7742)   Jim Racich Memorial
  (0.7742)   Stereotactic Radiosurgery
  (0.7742)   Mailing Lists
  (0.7742)   Mailing Lists
  (0.7742)   Brain Tumor Treatments: Japan
  (0.7742)   Brain Tumor Treatments: Italy
  (0.7742)   Brain Tumor Treatments: Israel
  (0.7742)   Brain Tumor Chat Room Question
  (0.7742)   Brain Tumor Chat room
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Brain Tumor Trials And Treatments
  (0.7742)   Immunotherapies, biological and targeted therapies
  (0.7742)   Immunotherapies, biological and targeted therapies
  (0.7742)   Image Guided Surgery
  (0.7742)   Brain Tumor Treatments: Illinois
  (0.7742)   IFN-Beta Gene Transfer
  (0.7742)   2003 Pediatric Brain Tumor Confernce
  (0.7742)   Video Library: Brainstorming Long Island 2004
  (0.7742)   Hockey fundraiser
  (0.7742)   Hockey fundraiser
  (0.7742)   Human Corticotropin-Releasing Factor (hCRF)
  (0.7742)   Brain Tumor Chat Room
  (0.7742)   Brain Tumor Chat room




Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2010 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By
World Wide Websites